Highmark Health’s VITAL Innovation Platform testing benefits of innovations from Sensible Medical related to measurement of lung fluid in patients with congestive heart failure
The VITAL platform is testing Sensible Medical’s ReDS Fluid Monitoring System through July of 2019 among 100 patients with recent congestive heart failure admissions who are being discharged from an Allegheny Health Network hospital to a skilled nursing facility. The ReDS system features a noninvasive “vest” that within 90 seconds can supplement the stethoscope by using radio frequency technology to provide an objective measure of congestion in the lungs related to pulmonary edema. If threshold levels of fluids exist, patients would remain in the nursing facility for further treatment until discharge levels are met. Using the ReDS system has the potential to reduce premature patient discharges that can result in emergency rooms episodes and costly hospital readmissions.
Spearheading the Sensible Medical ReDS test is lead investigator Dr. Srinivas Murali of Allegheny Health Network’s Allegheny General Hospital in Pittsburgh.